Lindenwold Advisors INC Acquires New Stake in Stevanato Group S.p.A. $STVN

Lindenwold Advisors INC acquired a new stake in Stevanato Group S.p.A. (NYSE:STVNFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 9,390 shares of the company’s stock, valued at approximately $229,000.

Other institutional investors have also bought and sold shares of the company. Hancock Whitney Corp lifted its position in shares of Stevanato Group by 4.8% during the first quarter. Hancock Whitney Corp now owns 11,482 shares of the company’s stock worth $234,000 after acquiring an additional 528 shares in the last quarter. Van Berkom & Associates Inc. lifted its position in shares of Stevanato Group by 33.3% during the first quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company’s stock worth $49,000 after acquiring an additional 600 shares in the last quarter. First Bank & Trust lifted its position in shares of Stevanato Group by 6.2% during the second quarter. First Bank & Trust now owns 16,142 shares of the company’s stock worth $394,000 after acquiring an additional 944 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its position in shares of Stevanato Group by 7.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,878 shares of the company’s stock worth $283,000 after acquiring an additional 1,004 shares in the last quarter. Finally, Whittier Trust Co. purchased a new stake in shares of Stevanato Group during the first quarter worth $27,000.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. William Blair restated an “outperform” rating on shares of Stevanato Group in a research report on Monday, June 30th. Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Stock Report on Stevanato Group

Stevanato Group Price Performance

Shares of NYSE STVN opened at €23.85 on Friday. The firm has a market capitalization of $7.22 billion, a P/E ratio of 44.17, a P/E/G ratio of 2.30 and a beta of 0.57. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25. The stock’s 50-day simple moving average is €24.46 and its two-hundred day simple moving average is €23.55. Stevanato Group S.p.A. has a twelve month low of €17.12 and a twelve month high of €28.00.

Stevanato Group Profile

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Stories

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVNFree Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.